Amgen (AMGN) Announces $650M Puerto Rico Facility Expansion

Amgen Inc. (NASDAQ:AMGN) ranks among the top picks for a retirement portfolio. On September 26, Amgen Inc. (NASDAQ:AMGN) unveiled a $650 million upgrade to its manufacturing facility in Juncos, Puerto Rico, which is estimated to create around 750 additional jobs. The investment will help to improve medicine production capacities and incorporate innovative technology across the operations process.

The announcement builds on Amgen’s recent investments, which include a $1 billion expansion in North Carolina, a $900 million factory expansion in Ohio, and a $600 million science and innovation center in California.

In support of its local manufacturing and research investments, the company pointed to the Tax Cuts and Jobs Act of 2017 and the One Big Beautiful Bill Act of 2025.

Amgen Inc. (NASDAQ:AMGN) is a global biopharmaceutical company that focuses on human treatments for cardiovascular, hematology, inflammation, cancer, and bone health.

While we acknowledge the potential of AMGN as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.

READ NEXT: 10 Best Magic Formula Stocks for 2025 and 10 Best Retirement Stocks to Buy According to Hedge Funds.

Disclosure: None. This article is originally published at Insider Monkey.